Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines

Anaphylaxis to vaccines is historically a rare event. The coronavirus disease 2019 pandemic drove the need for rapid vaccine production applying a novel antigen delivery system: messenger RNA vaccines packaged in lipid nanoparticles. Unexpectedly, public vaccine administration led to a small number...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Allergy Clin Immunol
Main Authors: Risma, Kimberly A., Edwards, Kathryn M., Hummell, Donna S., Little, Frederic F., Norton, Allison E., Stallings, Amy, Wood, Robert A., Milner, Joshua D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Academy of Allergy, Asthma & Immunology 2021
Assuntos:
Covid-19
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8056854/
https://ncbi.nlm.nih.gov/pubmed/33857566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2021.04.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados